Monograph
J07BG01 - Rabies, Inactivated, Whole Virus |
Propably not porphyrinogenic |
PNP |
Rationale
Based on the pharmacokinetics of the rabies, inactivated, whole virus vaccine, there are no conceivable porphyrinogenic effects.
Chemical description
Inactivated rabies virus.
Therapeutic characteristics
The rabies vaccine is indicated for pre-exposure and post-exposure prophylaxis against rabies. It is administered intramuscular according to a three or five dose schedule.
Metabolism and pharmacokinetics
The rabies vaccine is not metabolized by the cytochrome P450 system.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Government bodies | |
| 1. | Norwegian Institute of Public Health. Vaksinasjonsveilederen. www.fhi.no (updated 13.10.2015).
|
|
| * | Summary of Product Characteristics | |
| 2. | The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). Rabipur. (Last edition: 03.12. 2015).
|
|
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Rabipur · Verorab 
Rabipur · Verorab i.derm./i.m. 
Rabipur · Verorab Precargada. Vacuna Antirrabica 
Verorab 
Rabies Vaccine · Rabipur · Rabipur vaccine · Verorab 
Rabipur · Verorab 
Rabipur · Verorab 
Rabipur · Verorab 
Rabipur 
Verorab
© NAPOS 2025